This metabolic brain boost revives memory in Alzheimer’s mice
An experimental cancer drug that helps the brain turn glucose into energy was able to reverse memory loss in a mouse model of Alzheimer’s disease.
Alzheimer's disease
New blood tests can help diagnose Alzheimer's. Are doctors ready for what's next?
A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.
A protein called Reelin keeps popping up in brains that resist aging and Alzheimer’s
Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer’s and other threats to memory and thinking.
FDA approves a second Alzheimer's drug that can modestly slow disease
The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.
FDA approves a second Alzheimer's drug that can modestly slow disease
The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.
'The beginning of better ways to treat Alzheimer’s disease' comes to the Triad
On Thursday, Atrium Health Wake Forest Baptist became the first health system in the region to treat an Alzheimer's disease patient with the new medication lecanemab, according to the Winston-Salem-based health system.
Blood tests can help diagnose Alzheimer's — if they're accurate enough. Not all are
A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.
Facing my wife's dementia: Should I fly off to see our grandkids without her?
After 40 years of living and travelling together, a writer considers a trip without his wife. He can't explain where he's going or why he can't bring her along.
An experimental Alzheimer's drug outperforms one just approved by the FDA
In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.
Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow
The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.